A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression | NobleBlocks
Public
A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression
Published in Science Translational Medicine • Jun 9, 2021
Authors:
Peter Nägele
,
Ben Julian A. Palanca
,
Britt M. Gott
Abstract
< 0.001). These results suggest that 25% nitrous oxide has comparable efficacy to 50% nitrous oxide in improving TRMD but with a markedly lower rate of adverse effects.
